Use of copper oxide wire particles to control gastrointestinal nematodes in goats.
The objectives of these experiments were to determine the optimal dose of copper oxide wire particles (COWP) necessary to reduce gastrointestinal nematode (GIN) infection in young and mature goats naturally infected with Haemonchus contortus or a mixed infection and to determine whether the effectiveness could be enhanced through feeding management. Two experiments were conducted during cooler months in Georgia, and 4 experiments were conducted during warmer spring or summer months in Arkansas. Meat goats received 0 up to 10 g of COWP under a variety of management conditions. In all experiments, blood and feces were collected every 3 or 7 d from 6 to 42 d to determine blood packed cell volume (PCV) and fecal egg counts (FEC) to estimate the degree of GIN infection. In mature goats grazing fall pasture, mean FEC of 0 g of COWP-treated goats increased, and those of 4 g of COWP-treated goats remained low on d 0, 7, and 14 (COWP x d, P < 0.03), and FEC decreased on these days (P < 0.001). In 5 and 10 g of COWP-treated goats, PCV increased (P < 0.001), but FEC and PCV remained unchanged over time in control goats. Fecal egg counts were similar among all low doses (0.5, 1, 2, 4 g) of COWP administered to weaned kids for all dates examined (P > 0.10), which were lower on d 7 through 21 (COWP x date, P < 0.05) but similar by d 28, compared with FEC of 0 g of COWP-treated kids. Packed cell volume was lower in 0 g compared with all COWP-treated kids by d 14 (COWP x date, P < 0.05). Feeding management in combination with COWP for GIN control had little effect compared with COWP alone for these short-term studies. In conclusion, a dose of COWP as low as 0.5 g, which was considered optimal to reduce the risk of copper toxicity, was effective in reducing FEC in young goats, and 5 g of COWP was effective in older goats. Copper oxide does not appear to be effective in controlling newly acquired L4 stage (preadult) larvae, which also feed on blood, leading to decreased PCV in newly infected goats.
Burke
J M
JM
ARS, USDA, Booneville, AR 72927, USA. jmburke@spa.ars.usda.gov
Terrill
T H
TH
Kallu
R R
RR
Miller
J E
JE
Mosjidis
J
J
D000821:Animal Feed; D000818:Animals; D000969:Antinematodal Agents / Q000494:pharmacology* / Q000627:therapeutic use; D003300:Copper / Q000494:pharmacology* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005243:Feces / Q000469:parasitology; D005260:Female; D015511:Goat Diseases / Q000188:drug therapy* / Q000517:prevention & control; D006041:Goats; D006188:Haemonchiasis / Q000188:drug therapy / Q000517:prevention & control / Q000662:veterinary*; D010270:Parasite Egg Count / Q000662:veterinary; D011897:Random Allocation; D012621:Seasons; D014131:Trace Elements / Q000494:pharmacology; D016896:Treatment Outcome
D000969:Antinematodal Agents; D014131:Trace Elements; D003300:Copper; C030973:cupric oxide